Home Financial Markets Xenetic Biosciences Inc. (NASDAQ:XBIO) stock surged in the afterhours trading session; here’s...

Xenetic Biosciences Inc. (NASDAQ:XBIO) stock surged in the afterhours trading session; here’s why

At the time of writing, Xenetic Biosciences Inc. (XBIO) stock had surged by 7.69% to the price of $2.1 in the after-market trading session. XBIO stock previously closed the session at $1.95 losing -0.51%. The XBIO stock volume traded for 0.26 million shares. The current trade volume for the past 3 months has been 321.36K. In the past year up-to-date, XBIO stock jumped up by 126.74%. In the past week, the shares have moved down by -3.94%. In the past three and six months, the XBIO stock lost -20.73% while it gained 133.64% respectively. Furthermore, Xenetics Biosciences Inc. is currently valued in the market at $17.80 million and has 8.75 million outstanding shares.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

What we know about Xenetic Biosciences Inc.

Xenetic Biosciences, Inc., a biopharmaceutical company with a focus on discovering, researching, and developing of novel treatments and therapy products which include biologic drugs and novel oncology therapeutics. The company is headquartered in Framingham, Massachusetts.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

XBIO stock has a proprietary drug delivery system which it created through partnerships with biotechnology and pharmaceutical companies. This drug delivery platform is known as PolyXen.The product offering of the company also includes drug platform which includes the chimeric antigen receptor T cell which has been personalized (CAR T) and developed for the targeting of specific tumor neoantigens in the patients. This system is known as XCART. The malignant tumor cells are targeted through their B-cell receptors and provide treatment to the B-cell lymphomas.

XBIO’s leading drug platform XCART received approval for exploratory study

On 29th March 2021, the company announced that it has initiated the advancement of its drug platform of chimeric antigen receptor T cell for targeting specific tumor neoantigens known as XCART. This plan of action was decided right after Xenetic Biosciences Inc. received approval to for XCART’s exploratory study; initiating the exploratory patient biopsy which it was aiming to apply in the Eastern Europe.

From a preclinical point of view, this is a crucial step in the right direction for the development program to progress in and now NHL patients will be taken under evaluation for their treatment at study site or the samples of tumor are taken on which experimental and exploratory evaluation is done.

Potential for the study’s advancement means good news for XBIO stock

The study has been structured in such a format that Xenetic states it will allow them to potentially study the phase 1 in the future; evaluation of dosing of patients with the autologous CAR T products as well as other certain clinical parameters that are associated with the study. This study also has the potential to position the company into US IND-enabling programs.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Xenetic Biosciences Inc. is collaborating with Scripps Research as well as PJSC Pharmasenthez for studying the XCART platform as they had previously done so on preclinical development stages of XCART and were co-inventors of this technology. The platform is specifically being studied in collaboration for finding ways to advance the development of B-cell malignancies.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Why did Corvus Pharmaceuticals Inc. (CRVS) stock soar on Wednesday?

Corvus Pharmaceuticals Inc. (CRVS) shares surged 9.17% in after-hours on Wednesday, July 28, 2021, and closed the daily trading at $2.38. in the regular...

Havertys Furniture Companies Inc. (HVT) stock gains during after-hour trading, Here’s to know why?

Havertys Furniture Companies Inc. (NASDAQ: HVT) stock declined by 0.39% at last close whereas the HVT stock price gains by 4.6% in the after-hours...

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Flora Growth Corp. (FLGC) stock declines during premarket. Here’s what you should know?

Flora Growth Corp. (NASDAQ: FLGC) stock gained by 49.67% at last close whereas the FLGC stock price plunged by 18.36% in the pre-market trading...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Why Gaotu Techedu Inc. (GOTU) stock went up on Wednesday despite headwinds?

Gaotu Techedu Inc. (GOTU) shares rose 1.38% in after-hours on Wednesday, July 28, 2021, and closed the daily trade at $3.67. Earlier in the...

Why did Corvus Pharmaceuticals Inc. (CRVS) stock soar on Wednesday?

Corvus Pharmaceuticals Inc. (CRVS) shares surged 9.17% in after-hours on Wednesday, July 28, 2021, and closed the daily trading at $2.38. in the regular...

Antero Resources Corp. (AR) stock fell during after-market. Here’s to know why?

Antero Resources Corp. (NASDAQ: AR) stock plunged by 0.58% at last close while the AR stock price declines by 6.59% in the after-hours trading...

Related News

Orion Group Holdings Inc. (ORN) stock declines in pre-market trading. Here’s the update.

Orion Group Holdings Inc. (ORN) stock gained by 3.46% at last close while the ORN stock price plunged by 3.85% in the pre-market trading....

Why Gaotu Techedu Inc. (GOTU) stock went up on Wednesday despite headwinds?

Gaotu Techedu Inc. (GOTU) shares rose 1.38% in after-hours on Wednesday, July 28, 2021, and closed the daily trade at $3.67. Earlier in the...

Teladoc Health Inc. (TDOC) stock declines during after-hour trading session. What’s the update?

Teladoc Health Inc. (TDOC) gained by 0.84% at the last close whereas the TDOC stock price plunged by 8.58% in the after-market. By changing...

Relmada Therapeutics Inc. (RLMD) stock is plunging in the current trading session; What’s going on?

In the current trading session, Relmada Therapeutics Inc. (RLMD) stock shares are plunging by -5.97%. The current trading price is at $23.62 in the...

Helix Energy Solutions Inc. (HLX) stock fell during pre-market. What’s behind this decline?

Helix Energy Solutions Group Inc. (HLX) stock gained by 4.54% at the last close whereas the HLX stock price plunged by 6.72% in the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam